|
|
Blood, 1 July 2006, Vol. 108, No. 1, pp. 123-133.
Prepublished online as a Blood First Edition Paper on March 9, 2006; DOI 10.1182/blood-2005-11-4458.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo
Ying Liu,
Ramona Pop,
Cameron Sadegh,
Carlo Brugnara,
Volker H. Haase, and
Merav Socolovsky
From the Department of Pediatrics and Department of Cancer Biology, University of Massachusetts Medical School, Worcester; Department of Biology, Massachusetts Institute of Technology, Cambridge; Department of Laboratory Medicine, Children's Hospital, Harvard Medical School, Boston, MA; and Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.
Erythropoietin (Epo) is the principal regulator of the erythropoietic response to hypoxic stress, through its receptor, EpoR. The EpoR signals mediating the stress response are largely unknown, and the spectrum of progenitors that are stress responsive is not fully defined. Here, we used flow cytometry to identify stress-responsive Ter119+CD71HIGHfscHIGH early erythroblast subsets in vivo. In the mouse spleen, an erythropoietic reserve organ, early erythroblasts were present at lower frequencies and were undergoing higher rates of apoptosis than equivalent cells in bone marrow. A high proportion of splenic early erythroblasts coexpressed the death receptor Fas, and its ligand, FasL. Fas-positive early erythroblasts were significantly more likely to coexpress annexin V than equivalent, Fas-negative cells, suggesting that Fas mediates early erythroblast apoptosis in vivo. We examined several mouse models of erythropoietic stress, including erythrocytosis and -thalassemia. We found a dramatic increase in the frequency of splenic early erythroblasts that correlated with down-regulation of Fas and FasL from their cell surface. Further, a single injection of Epo specifically suppressed early erythroblast Fas and FasL mRNA and cell-surface expression. Therefore, Fas and FasL are negative regulators of erythropoiesis. Epo-mediated suppression of erythroblast Fas and FasL is a novel stress response pathway that facilitates erythroblast expansion in vivo. (Blood. 2006;108:123-133)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. L. Chen, T. D. Logan, M. L. Hochberg, S. G. Shelat, X. Yu, G. E. Wilding, W. Tan, G. C. Kujoth, T. A. Prolla, M. A. Selak, et al.
Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction
Blood,
November 5, 2009;
114(19):
4045 - 4053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Norton, K. A. Fortner, P. Bizargity, and E. A. Bonney
Pregnancy Alters the Proliferation and Apoptosis of Mouse Splenic Erythroid Lineage Cells and Leukocytes
Biol Reprod,
September 1, 2009;
81(3):
457 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Huo, S. C. McConnell, and T. M. Ryan
Preclinical transfusion-dependent humanized mouse model of {beta} thalassemia major
Blood,
May 7, 2009;
113(19):
4763 - 4770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tang, S. Chen, H. Wang, H. Wu, Q. Lu, and D. Han
TAM receptors and the regulation of erythropoiesis in mice
Haematologica,
March 1, 2009;
94(3):
326 - 334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Carmichael, I. J. Majewski, W. S. Alexander, D. Metcalf, D. J. Hilton, C. A. Hewitt, and H. S. Scott
Hematopoietic defects in the Ts1Cje mouse model of Down syndrome
Blood,
February 26, 2009;
113(9):
1929 - 1937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Minella, K. R. Loeb, A. Knecht, M. Welcker, B. J. Varnum-Finney, I. D. Bernstein, J. M. Roberts, and B. E. Clurman
Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo
Genes & Dev.,
June 15, 2008;
22(12):
1677 - 1689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Lamikanra, D. Brown, A. Potocnik, C. Casals-Pascual, J. Langhorne, and D. J. Roberts
Malarial anemia: of mice and men
Blood,
July 1, 2007;
110(1):
18 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rimmele, O. Kosmider, P. Mayeux, F. Moreau-Gachelin, and C. Guillouf
Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation
Blood,
April 1, 2007;
109(7):
3007 - 3014.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|